Search Videos and More
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
News
Temple Lung Center: Advancing Research in ILD
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.
News
March Quarterly Impact Report: Temple Healthy Chest Initiative
screenings since program inception. Research shows that roughly 70% of patients undergoing lung cancer screening will have some radiographic abnormality in their scan results. This report outlines steps the Temple Healthy Chest Initiative has taken to scale screening efforts in order to detect a wide range of chest conditions at earlier stages.
Course
2025 GOLD International COPD Conference
Hosted in partnership by The Temple Lung Center and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), this conference will be presented in a hybrid format with in-person sessions virtually simulcast to a global audience of healthcare providers involved in the care and management of people with COPD. Learn alongside other dedicated COPD practitioners, and hear directly from leading experts and researchers.
News
Temple Lung Center: Advances in Lung Care and Research in 2024
The Temple Lung Center continued to set the standard in lung health throughout 2024, delivering exceptional clinical care and advancing lung disease research. Through expanded screening programs and innovative clinical trials, our multidisciplinary team—including pulmonologists, thoracic surgeons, and other specialists—provided patients with breakthrough options for diagnosing and treating even the most complex lung conditions.
Video
LDCT+: A New Approach in Early Lung Disease Detection - Webinar
View Archive of this live webinar | Annual low-dose computed tomography (LDCT) screening has transformed early lung cancer detection, yet many patients remain underdiagnosed for coexisting conditions like COPD—an independent risk factor for lung cancer and a major comorbidity affecting survival.
Course
Interstitial Lung Disease (ILD) and Associated Pulmonary Hypertension
Interstitial lung disease (ILD) is a commonly encountered disease state. Patients who develop ILD associated with pulmonary hypertension have an increased mortality risk. This program aims to review the classification of commonly encountered interstitial lung diseases. Secondly, to describe the pathophysiology that leads to the development of ILD associated pulmonary hypertension. Lastly, to review a diagnostic approach to ILD associated pulmonary hypertension along with treatment options.
News
Temple Lung Center: Advancing Research in COPD
The Temple Lung Center is one of the world’s largest COPD research centers, and has demonstrated its commitment to offer innovative therapies to patients by applying research breakthroughs to clinical care.
Video
Lung Transplantation for COPD Patients
Chronic Obstructive Pulmonary Disease (COPD) is the sixth leading cause of death in the U.S., affecting nearly 16 million adults. Dr. Gerard Criner, Director of the Temple Lung Center, recently joined the Global Forum on Lung Transplantation to explore the role of lung transplantation for COPD.
News
November Quarterly Impact Report: The Temple Healthy Chest Initiative
The American Cancer Society is forecasting more than two million new cases of cancer to be diagnosed in the year 2024. And while the incidence rate is on the rise, cancer-related deaths continue to decline. Early detection is key to producing better outcomes for patients.
Video
What is new in 2024 for PE
A comprehensive overview of strategic clinical risk stratification, evidence-based approaches derived from clinical trials and advanced research, and essential insights into the follow-up care of patients post-pulmonary embolism (PE).
Course
2024 GOLD International COPD Conference
Join us on November 11th and 12th for the world’s largest educational symposium on chronic obstructive pulmonary disease (COPD). The upcoming 9th annual GOLD International COPD Conference is once again a two-day event hosted in Philadelphia, Pennsylvania.